Plants produce a vast array of bioactive natural products that underpin medicine and industry. Despite their value, many of these compounds remain difficult to extract or chemically synthesise.
Our research deciphers the genetic and biochemical pathways responsible for these molecules, enabling us to develop scalable production platforms for high-value pharmaceutical and industrial applications.
Reconstructing complex plant terpene pathways to develop sustainable, bio-based chemical production platforms for health, crop, and personal care sectors.
Unravelling the genomic architecture of opium poppy to elucidate metabolic pathways, enabling the molecular breeding of elite pharmaceutical crop varieties
Employing Euphorbia peplus as a model system to unravel macrocyclic diterpenoid biosynthesis and engineer precursor-optimised expression platforms for crop security.
Utilising biochemical genetics to develop high-yielding, non-GM artemisinin hybrids, stabilising the global anti-malarial supply chain to deliver millions of treatments.